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Abstract 
Background: Ovarian endometriosis is a common disease found in women of childbearing age. Existing therapies in 
western medicine have limitations in various aspects including management of pain, prevention of recurrence and 
promotion of fertility. Numerous Chinese medicine preparations have been shown to possess therapeutic potential in 
relieving EMS symptoms and shrinking the OEMS without significant adverse effects, although the clinical efficacy 
needs to be further confirmed with large amounts of well-designed experiments.  
Objectives and Methods: RCTs of Chinese medicine concerning ovarian endometriosis are included to work out this 
systematic review in order to provide scientific evidence for its efficacy and safety. 
Results: 16 articles were selected out of 427 literatures for a systematic reviews and a meta-analysis was conducted. 
The studies suggest that the ovarian endometriosis patients’ recurrence rate is lower and the pregnancy rate is higher 
in the Chinese medicine group, while the total effective rate, change in the size of endometrial cyst and CA125 level in 
both Chinese and Western medicine groups shows no statistical significance. Although the result favored the Chinese 
medicine group for lower dysmenorrhea rate and less adverse effects, the size of sample data and high heterogeneity 
between studies adversely affected the reliability of the results. 
Conclusion: Chinese medicine has two advantages over Western medicine in treating ovarian endometriosis, which 
are the low recurrence rate and high pregnancy rate. However, due to the limited number of literatures available and 
variations in their experimental methods and outcome measures, the conclusive results remain elusive. Larger scales 
of randomized controlled trials and more scientific evidence are needed to prove the efficacy and safety of Chinese 
medicines for ovarian endometriosis. 
Keywords: Ovarian endometriosis; Chocolate cyst; Traditional Chinese medicine; Randomized controlled trial; 
Systematic review 
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Introduction 
     Ovarian endometriosis (OEM) is a hormone-
dependent disease characterized by the unusual growth 
of endometrial tissue inside the ovaries. It behaves in 
malignant manner, for example, endometriosis can be 
distantly metastatic, invasive, and rapidly recurring. A 
French epidemiological study released in 2016 shows 
that, endometriosis patients account for 1.5% of 
14,239,197 hospitalized women at childbearing age [1]. 
The increasing incidence rate of endometriosis, due to 
early menarche, late menopause and advanced maternal 
age, contribute to the burden of ill health in women [2]. 
According to The American Congress of Obstetricians 
and Gynecologists (ACOG), 54.9% endometriotic growth 
occurs at the ovary, the most common site of 
endometrial implantation [3]. Approximately 80% OEM 
are unilateral ovarian endometriosis, while around 50% 
of them involve both ovaries [3-5]. Although surgical 
approaches have been recommended as a definitive 
management of OEM, surgical treatment is an invasive 
procedure and causes tissue injury. Pharmacological 
therapies are effective in reducing the size of OEM and 
relieving symptoms. However, rapid recurrence and 
broad adverse side effects have largely limited the use of 
pharmacotherapy. A search for alternative treatment 
strategies is therefore needed. Numerous Chinese 
medicine preparations have been shown to possess 
therapeutic potential in relieving OEM symptoms and 
shrinking the OEM size without significant adverse 
effects, although the clinical efficacy needs to be further 
confirmed. On the basis of empirical evidence and 
clinical practice, randomized controlled trials (RCTs) of 
Chinese medicine concerning ovarian endometriosis are 
located to conduct a systematic review for assessing its 
efficacy and safety. 
 
Materials and Methods 
Search Method 
     We searched for published RCTs of Chinese Medicine 
for ovarian endometriosis with the English keywords 
“Traditional Chinese medicine, Chinese medicine, 
Chinese herbal medicine, Herbal medicine, ovarian 
endometriosis, Chocolate cyst” and Chinese keywords 
“中醫，中藥，卵巢子宮內膜異位症，巧克力囊腫 ”. 
Searching strategy used was presented in the figure 
below (Figure 1). The following databases were searched: 
MEDLINE (from 1950 to Jan 2016); PubMed (from 1927 
to Jan 2016); Wan Fang Database (Chinese Ministry of 
Science and Technology) (from 1980 to Jan 2016); and 
China National Knowledge Infrastructure (CNKI) (from 
1915 to Jan 2016).We also screened bibliographies of the 
selected articles and searched manually for any internet 
inaccessible articles. The language of the articles was 
limited to English and Chinese. Publications without full 
text were excluded. 
 
 
 
Figure 1: Searching strategy for English and Chinese RCTs 
Systematic Review 
Inclusion Criteria 
 Types of Studies: All RCTs reporting the 
applications of Chinese Medicine to OEM. 
 Participants: Ovarian endometriosis patients 
diagnosed by laparoscopy, medical imaging 
examination or pathological examination. 
 
 Interventions: All types of Chinese medicines of 
oral administration in either standard or combined 
formulas are accepted in the treatment group. All 
types of Western medicines are accepted in the 
control group. 
 Outcome Measures: The effective rate, recurrence 
rate, pregnancy rate and also the safety of the 
intervention were studied. 
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Exclusion Criteria 
 Other Participants: Suspected OEM diagnosis 
without laparoscopy, medical imaging examination 
or pathological examination was excluded. 
 Combined Therapies: If the intervention combined 
Chinese medicines with therapies other than 
surgical therapy, the study would be excluded. 
 Other Type of Studies: Case reports, commentary 
studies, and review articles were excluded. 
Data Extraction and Quantitative Analysis: 16 articles 
were selected out of 427 literatures and the exclusion 
criteria were presented in the PRISMA flow diagram 
below (Figure 2). Extraction forms were designed for 
data extraction from the selected publications 
quantitatively.  
 
 
Figure 2: PRISMA Flow Diagram: Study inclusions and exclusions for systematic review. 
 
 
Meta-analysis 
Data Synthesis: We carried out the statistical analysis 
using RevMan5.3. Quantitative data was analyzed by 
standard mean differences (SMD), while categorical 
variables were analyzed with using odds ratio (OR) and 
relative risk (RR). If substantial statistical heterogeneity 
(P<0.05) were detected, random effects model (RE) 
would be selected, otherwise, fixed model (FE) would be 
used for homogeneity (P>0.05). Results were presented 
in forest plot with its 95% confidence interval. Funnel 
plot would be used in presenting potential publication 
bias if necessary. Characteristics of the included studies 
and also their risk of bias were presented as follow 
(Tables 1 & 2). 
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Study Case 
Chinese 
Medicine 
Western 
Medicine 
Outcome Measure 
Experi-
ment # 
Follow 
up # 
Bai, et al. 
2011 [6] 
88 
Yu Tong Shu 
Pills 
Danazol 
Effective rate, recurrence rate, 
dysmenorrhea rate, change in 
nodules tenderness, CA125 level 
6 18 
Cao, et al. 
2008 [7] 
60 
E-leng 
capsule 
Danazol 
Recurrence rate、MMP-9 mRNA & 
TIMP-1 mRNA expression 
6 9 
Ding Shi 
2012 [8] 
56 
Traditional 
Chinese 
Medicine 
Namestran 
(Gestrinone) 
Effective rate, pregnancy rate, 
adverse event rate 
6 3 
Ge Cao 2014 
[9] 
92 
Compound 
EZhu powder 
Mifepristone, 
Gestrinone 
Effective rate, recurrence rate, 
pregnancy rate, adverse event rate 
6 6 
Huang, et al. 
2008 [10] 
50 
E-leng 
capsule 
Namestran 
(Gestrinone) 
Dysmenorrhea rate, change in the 
diameter of endometrial cyst, CA125 
level, PRL level, positive rate of 
serum EmAb, adverse event rate 
4 0 
Li 2012 [11] 94 
Dan E Fu 
Kang Jian 
Plaster 
Gestrinone Effective rate, recurrence rate 6 0 
Li, et al. 2011 
[12] 
61 
Mu Da 
Decoction 
Gestrinone 
Pelvic pain rate, change in the 
diameter of endometrial cyst, CA125 
level, adverse event rate 
6 0 
Liu, et al. 
2015 [13] 
80 
Jian Pi Wen 
Shen 
Decoction 
Mifepristone Effective rate, adverse event rate 3 6 
Luo, et al. 
2016 [2] 
50 
Bu 
ShenHuoXue 
San Yu 
Decoction 
Mifepristone 
Effective rate,dysmenorrhea rate, 
score in TCM symptoms, change in 
the size of endometrial cyst, CA125 
level 
3 3 
Shan 2011 
[14] 
82 
WenShenHua 
Yu Decoction 
Mifepristone 
Effective rate, recurrence rate, 
pregnancy rate, adverse event rate 
6 24 
Wang Xiao 
2013 [15] 
86 
Dan E Fu 
Kang Jian 
Plaster 
Gestrinone Effective rate, recurrence rate 6 0 
Xia, et al. 
2014 [16] 
66 
Zheng's Yi 
Wei Gui Yuan 
Decoction 
Goserelin 
Effective rate, recurrence rate, 
adverse event rate 
6 12 
Yan 2014 
[17] 
498 
Hua Yu 
Decoction 
Penicillin, 
Gentamicin, 
Norfloxacin, 
Spiramycin 
Effective rate 1 3 
Yang, et al. 
2014 [18] 
96 
Traditional 
Chinese 
Medicine 
Gestrinone 
Dysmenorrhea rate, change in the 
diameter of endometrial 
cyst,adverse event rate 
3 0 
Zhou Song 
2013 [19] 
60 
Bu 
ShenHuoXue 
Decoction 
Leuprorelin 
Effective rate, recurrence rate, 
pregnancy rate, adverse event rate 
6 6 
Zhu, Lei 2010 
[20] 
100 
Dan E Fu 
Kang Jian 
Plaster 
Gestrinone 
Effective rate, recurrence 
rate,dysmenorrhea rate, 
lumbosacral bulge improvement 
rate, dyspareunia improvement rate 
6 36 
 
# Experiment and follow up duration measured in month(s). 
Table 1: Characteristics of the included studies [2,6-19]. 
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Table 2: Risk of bias of the included studies. 
 
 
Results and Discussion 
     16 clinical literatures were selected according to the 
inclusion and exclusion criteria, in which, 1619 cases 
were included. One of the selected clinical literatures 
included 3 groups, which can be seen as two randomized 
controlled trials. Hence, 17 randomized controlled trials 
were included in this study. 
 
Chinese Medicine for Ovarian Endometriosis 
Therapeutic Principles: Chinese medicine treats the 
 
 human body as a whole system. Its therapeutic principle 
aims at resolving the causes of the disease and helps 
body in restoring internal dynamic balance, hence, 
relieving the symptoms. Amongst all the selected RCTs, 
“invigorating blood circulation” (78.57%) and 
“eliminating blood-stasis” (64.29%) were the most 
common therapeutic principle applied (Table 3). Less 
common ones included “resolving masses and swelling” 
(50.00%), “regulating the flow of vital energy/ 
dispersing the depressed liver-energy” (50.00%) and 
“tonifying the kidney” (35.71%). 
 
Therapeutic Principle Frequency* (%) 
Invigorates blood 11 (78.57%) 
Disperses stasis 9 (64.29%) 
Resolves accumulation, disperses accumulation 7 (50.00%) 
Moves Qi,courses the liver 7 (50.00%) 
Supplements the kidney 5 (35.71%) 
 
∗ % is the number of RCT using each therapeutic principle/ the number of included clinical trials× 100. 
Table 3: Therapeutic principles application of Chinese medicines for ovarian endometriosis. 
 
Individual Chinese Medicines: Amongst all the 
individual Chinese medicine studied for ovarian 
endometriosis (Table 4), Blue Turmeric Rhizome was the 
most frequently used individual Chinese medicine 
(62.5%). The top 10 most commonly used single Chinese 
medicines included Blue Turmeric Rhizome, Common 
Burreed Tuber, Yanhusuo Tuber, Red Paeoniae 
Trichocarpae, Dan-shen Root, Liquorice Root, Nutgrass 
Galingale Rhizome, Mongolian Milkvetch Root/ 
Membranous Milkvetch Root, Chinese Angelica, and 
Chinese Thorawax Root in descending order. The 
frequently used herbs in the clinical trials were recorded 
and listed below. 
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Order 
English 
name 
Latin 
pharmaceutical 
name 
Chinese 
name 
Frequency* 
(%) 
Daily 
dose 
(g)a 
Therapeutic actions 
1 
Blue 
Turmeric 
Rhizome 
Curcumae 
Phaeocaulis 
Rhizoma 
莪朮 10 (62.5%) 10-15 
Breaks blood, disperses 
accumulations, moves Qi, 
relieves pain. 
2 
Common 
Burreed 
Tuber 
Sparganii 
Rhizoma 
三棱 9 (56.25%) 10-15 
Breaks blood, moves Qi, 
resolves accumulation, stops 
pain. 
3 
Yanhusuo 
Tuber 
Corydalis 
Yanhusuo 
Rhizoma 
延胡索 9 (56.25%) 5-10 
Invigorates blood, disperses 
stasis, moves Qi, stops pain. 
4 
Red 
Paeoniae 
Trichocarpae 
Paeoniae Rubra 
Radix 
赤芍 9 (56.25%) 12-20 
Clears heat, cools the blood, 
disperses stasis, and relieves 
pain. 
5 
Dan-shen 
Root 
Salviae 
Miltiorrhizae 
Radix 
丹參 7 (43.75%) 15-30 
Invigorates the blood, regulates 
menstruation, dispels stasis, 
relieves pain, cools blood, 
relieves ulcer, clears the heart, 
eliminates vexation, nourishing 
the blood and calming mental 
state. 
6 
Liquorice 
Root 
Glycyrrhiizae 
Radix 
甘草 7 (43.75%) 5-6 
Supplements the spleen, boosts 
Qi, clears heat, resolves toxin, 
dispels phlegm, relieves cough, 
relaxes tension, relieves pain, 
and harmonizes the nature of 
other medicinal. 
7 
Nutgrass 
Galingale 
Rhizome 
Cyperi Rhizoma 香附 6 (37.5%) 12-15 
Moves Qi, resolves depression, 
regulates menstruation, and 
relieves pain. 
8 
Mongolian 
Milkvetch 
Root; 
Membranous 
Milkvetch 
Root 
Astragali 
Mongolici Radix; 
Astragali 
Menbranacei 
Radix 
黃耆 5 (31.25%) 10-20 
Supplements Qi, secures the 
exteriordefence, promotes 
urination, outthrusts toxin, 
expels pus, closes sore, and 
engenders flesh. 
9 
Chinese 
Angelica 
Angelicae 
Sinensis Radix 
當歸 5 (31.25%) 10-15 
Supplements the blood, 
invigorates the blood, regulates 
menstruation, relieves pain, 
moistens the intestines, and 
frees the stool. 
10 
Chinese 
Thorawax 
Root 
Bupleuri 
Chinensis Radix 
柴胡 5 (31.25%) / b 
Harmonizes the interior and 
exterior, courses the liver, 
resolves depression, outthrust 
the exterior defense, discharge 
heat, upbears yang, and raises 
the sunken. 
∗ % is the number of RCT using each individual Chinese medicine/ the number of included clinical trials × 100. 
 Daily dose is the range of the reported daily dose in all included clinical trials. 
 Not provided. 
Table 4: Top 10 of most commonly used individual Chinese medicines for ovarian endometriosis. 
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Effectiveness 
     The meta-analysis in limited randomized clinical trials 
suggested that the ovarian endometriosis patients 
recurrence rate is lower and the pregnancy rate is higher 
in the Chinese medicine group, while the total effective 
rate, change in the size of endometrial cyst and CA125 
level in both Chinese and Western medicine groups 
shows no statistical significance. As shown in Figures 3 & 
4, both the 6-month recurrence rate [FE: 0.38, 95% CI, 
0.20-0.72, P=0.003 (P<0.05)] and the 12-month 
recurrence rate [FE: 0.30, 95% CI, 0.13-0.72, P=0.007 
(P<0.05)] of ovarian endometriosis in Chinese medicine 
group (Chinese Med) is lower than that in Western 
medicine group (Western Med). Although the 36-month 
recurrence rate in Chinese medicine group is also lower 
than that in Western medicine group [RE: 0.44, 95% CI, 
0.10-2.73, P=0.44] (Figure 5), the meta-analysis with 
only 2 randomized clinical trials provides limited 
support.
 
 
Figure 3: 6-Month recurrence rate of ovarian endometriosis. 
 
 
 
Figure 4: 12-Month recurrence rate of ovarian endometriosis. 
 
 
 
 
Figure 5: 36-Month recurrence rate of ovarian endometriosis. 
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     As shown in (Figure 6),the pregnancy rate in Chinese 
medicine group is higher than that in Western medicine 
group [FE: 2.32, 95% CI, 1.15-4.67, P=0.02 
(P<0.05)].Although the result favored Chinese medicines 
for lower dysmenorrhea rate and less adverse effect, the 
lack of sample data and high heterogeneity adversely 
affected the reliability of the result.  
 
 
 
 
Figure 6: Pregnancy rate of ovarian endometriosis patients. 
 
Implications for further studies on the use of 
Chinese medicine in treating ovarian 
endometriosis 
     This study suggests that Chinese medicine is more 
effective than Western medicine in treating ovarian 
endometriosis: the recurrence rate is lower and 
pregnancy chances are higher, while the occurrence of 
dysmenorrhea and other associated symptoms are 
lower. However, the clinical efficacy of Chinese medicine 
for ovarian endometriosis needs to be further confirmed 
with large amounts of well-designed experiments. 
Moreover, it is difficult to carry out blinded trials 
between Chinese and Western Medicine since:  
 
 Chinese Medicine is often boiled as a decoction drink 
in the clinical setting, which appearance and odor are 
difficult to create a Western Medicine look alike. 
 Unlike Western medicine, Chinese medicine treats 
OEM by its own mechanism other than amenorrhea, 
leading to a variety of clinical symptom improvements 
which is difficult to measure in blinded trials. The 
methodology of Chinese medicine studies is therefore 
specially crafted, as it would be difficult to follow the 
double blinded trial model for international standards. 
An implication for future study will be the creation 
and standardization of a method for Chinese medicine 
clinical trial studies. 
 
Future clinical Chinese Medicine studies should improve 
in the following:  
 
 Adequate description of the randomization of studies 
and the allocation concealment, and blinding of the 
outcome to decrease the risk of bias;  
 
 Provide data for both before and after changes in the 
clinical trials, according to international standards, 
and to clearly state each trial’s inclusion and exclusion 
criteria;  
 Description of the Chinese medicine prescription used, 
with a list of herbs and the net weight;  
 Use an international standardized diagnostic tool for 
diagnostic and scoring system;  
 Standardization of the reporting methods. 
 
Conclusion 
     In conclusion, Chinese medicine is more effective than 
Western medicine in treating ovarian endometriosis: the 
recurrence rate is lower and pregnancy chances are 
higher; while the effect of decreasing the size of 
endometriosis cyst is similar, while the chances of 
preventing reoccurrence of cyst and increasing the 
chances of pregnancy are higher. As pregnancy is the 
best method to curing endometriosis, the Chinese 
medicine treatment creates a positive cycle of enhancing 
the chances of pregnancy and curing the disease. There 
is medical and exploratory scientific research value in 
using Chinese medicine as a treatment method for 
ovarian endometriosis. There is need for future Chinese 
medicine clinical trials to be conducted based on an 
international standard, with bigger sample sizes, higher 
methodological quality, and be in accordance with 
Chinese medicine diagnostic and treatment theory. The 
future need to study and practice for the evaluation of 
Chinese medicine system, but also the direction of our 
efforts. 
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